| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/19/2013 | US8399408 Method for treating diabetes using neurturin |
| 03/19/2013 | US8399383 Used to assay simultaneously the presence, amount, and/or function of proteins present in a protein sample/chip, or to assay the presence, relative specificity, and binding affinity of each probe in a mixture of probes for each of the proteins |
| 03/19/2013 | US8399339 Nanosensors |
| 03/19/2013 | US8399262 Biosensor |
| 03/19/2013 | US8399261 Lateral flow assay system and methods for its use |
| 03/19/2013 | US8399258 Biological markers for longevity and diseases and uses thereof |
| 03/19/2013 | US8399247 Methods and apparatus for selectively processing eggs having identified characteristics |
| 03/19/2013 | US8399211 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/19/2013 | US8399210 Autoantigenes for improved diagnosis, prognosis and treatment of inflammatory neurological diseases |
| 03/19/2013 | US8399209 Homogeneous detection method |
| 03/19/2013 | US8399208 specifically measures the myeloperoxidase (MPO) content only, which is correlated with said cell activation status; via a myeloperoxidase (MPO) specific polyclonal or monoclonal antibody immunoassay |
| 03/19/2013 | US8399207 Monoclonal antibodies against osteopontin |
| 03/19/2013 | US8399206 Methods for diagnosis, prognosis and methods of treatment |
| 03/19/2013 | US8399205 Device and method for separation, concentration, and/or purification of cells |
| 03/19/2013 | US8399204 Method for screening of substance which alter GPR120-mediated cell-stimulating activities |
| 03/19/2013 | US8399203 Analysis of chemically crosslinked cellular samples |
| 03/19/2013 | US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same |
| 03/19/2013 | US8399201 Polypeptide complex of TRPM8 and calmodulin and its uses thereof |
| 03/19/2013 | US8399200 Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers |
| 03/19/2013 | US8399190 Magnetic lysis method and device |
| 03/19/2013 | US8399186 Simultaneous detection of metabolic enzyme activity and metabolite levels |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/19/2013 | US8398936 Capillary pump unit and flow cell |
| 03/19/2013 | US8398935 Sheath flow device and method |
| 03/19/2013 | US8398922 Highly sensitive oxygen sensor for cell culture |
| 03/19/2013 | US8398921 Chemical sensor using metal nano-particles and method for manufacturing chemical sensor using metal nano-particles |
| 03/19/2013 | US8398920 Drinking vessels and related systems and methods |
| 03/19/2013 | US8397550 Method for determining the ignitability of a fuel |
| 03/19/2013 | US8397549 System for formation of highly nonlinear pulses |
| 03/19/2013 | CA2705716C Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
| 03/19/2013 | CA2662573C Three-phase cyclonic fluid separator with a debris trap |
| 03/19/2013 | CA2606906C Fluorogenic measurment of thrombin activity in a thin layer of whole blood |
| 03/19/2013 | CA2604150C A magnetic resonance system and method to detect and confirm analytes |
| 03/19/2013 | CA2582775C Analytical test element with wireless data transmission |
| 03/19/2013 | CA2580090C Methods and systems for providing a nutraceutical program specific to an individual animal |
| 03/19/2013 | CA2556227C Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 03/19/2013 | CA2551905C Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 03/19/2013 | CA2514092C Novel cocrystallization of hydrochloric acid salt of an active agent |
| 03/19/2013 | CA2513251C Cancer therapy sensitizer |
| 03/19/2013 | CA2504323C Secretion-testing article |
| 03/19/2013 | CA2467455C Method of detection of prostate cancer |
| 03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 03/19/2013 | CA2286156C Method of harvesting rare cells from blood products |
| 03/19/2013 | CA1341634C Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues acertains de ces virus et, le cas echeant, a la vaccination contre le sida |
| 03/16/2013 | CA2789718A1 Method and system for measurement of reservoir fluid properties |
| 03/14/2013 | WO2013036974A1 Cellular uptake control systems |
| 03/14/2013 | WO2013036936A1 Microrna biomarkers for diagnosing parkinson's disease |
| 03/14/2013 | WO2013036872A1 Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients |
| 03/14/2013 | WO2013036819A1 Methods of increasing the number of target cells recovered from a fluid sample |
| 03/14/2013 | WO2013036813A1 Systems and methods for monitoring quality of cooking media |
| 03/14/2013 | WO2013036754A2 Methods and compositions for diagnosis of ovarian cancer |
| 03/14/2013 | WO2013036748A1 Bicyclo[6.1.0]non-4-yne reagents for chemical modification of oligonucleotides |
| 03/14/2013 | WO2013036620A1 Methods and compositions for cytometric detection of rare target cells in a sample |
| 03/14/2013 | WO2013036598A1 Measurement device with sensor array |
| 03/14/2013 | WO2013036535A1 Biomarker to measure drug efficacy in enteropathic disease |
| 03/14/2013 | WO2013036285A1 Diagnostic assay to predict cardiovascular risk |
| 03/14/2013 | WO2013036278A1 Integrated sensing device and related methods |
| 03/14/2013 | WO2013036239A1 Compositions and methods for detecting autoantibodies |
| 03/14/2013 | WO2013036187A1 Determination of bacterial infections of the genus rickettsia and possibly borrelia, in patients exhibiting symptoms of disease and being blood donors |
| 03/14/2013 | WO2013036165A1 Method for recognizing and identifying consignments of commercial gasolines |
| 03/14/2013 | WO2013036101A1 Rubber allergenic proteins and immunoassay derived thereof |
| 03/14/2013 | WO2013036064A2 Method for measuring concentration of proteins in cytoplasm solution |
| 03/14/2013 | WO2013036030A2 Method for noninvasive prediction or diagnosis of inflammation and infection in amniotic fluid of patients with premature rupture of membranes |
| 03/14/2013 | WO2013035861A1 Method for determining susceptibility to age-related macular degeneration, primer pair, probe, age-related macular degeneration diagnostic kit, therapeutic agent for age-related macular degeneration, and screening method for therapeutic agent for age-related macular degeneration |
| 03/14/2013 | WO2013035824A1 Cancer stem cell isolation |
| 03/14/2013 | WO2013035799A1 Antibody capable of binding to specific region of periostin, and method for measuring periostin using same |
| 03/14/2013 | WO2013035779A1 Method of analysis of intercell interactions |
| 03/14/2013 | WO2013035767A1 Fluorescent probe for use in detection of acidic environment |
| 03/14/2013 | WO2013035747A1 Polyketone porous film |
| 03/14/2013 | WO2013035727A1 Sugar chain detection method using photocrosslinking agent and molecular probe |
| 03/14/2013 | WO2013035688A1 Method for staining tissue |
| 03/14/2013 | WO2013035208A1 ANTIBODY AGAINST MUTANT α-ACTININ-4 |
| 03/14/2013 | WO2013035095A1 Methods for diagnosing cancer |
| 03/14/2013 | WO2013035074A1 Method for assaying plasminogen in a liquid medium, associated compositions and kit |
| 03/14/2013 | WO2013035071A1 Novel risk biomarkers for lung cancer |
| 03/14/2013 | WO2013035062A1 A method of preparing biological material |
| 03/14/2013 | WO2013034918A1 Measuring a property of molten glass |
| 03/14/2013 | WO2013034911A1 Products and methods |
| 03/14/2013 | WO2013034749A1 Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof |
| 03/14/2013 | WO2013034738A1 Autoimmune and inflammatory disorder therapy |
| 03/14/2013 | WO2013034688A1 Biosensor for point-of-care diagnostic and on-site measurements |
| 03/14/2013 | WO2013034687A1 Avibacterium paragallinarum rtx toxin |
| 03/14/2013 | WO2013034264A1 L-fabp based diagnosis of kidney injury after an acute event or after a surgical intervention |
| 03/14/2013 | WO2013034160A1 Methods for analyzing biological macromolecular complexes and use thereof |
| 03/14/2013 | WO2013033933A1 Kit, process and use for measuring and evaluating sensitivity of ovarian cancer to primary chemotherapy |
| 03/14/2013 | WO2013012498A9 Electric cell- substrate impedance sensing (ecis) of biological samples in shear stress flow |
| 03/14/2013 | WO2013011381A3 Device and method for analyzing volatile organic compounds in gaseous samples |
| 03/14/2013 | WO2013011056A3 Pathology biomarker assay |
| 03/14/2013 | WO2013010140A3 Methods of diagnosing cancer |
| 03/14/2013 | WO2013008102A3 Methods and compositions for evaluating and/or treating chronic immune diseases |
| 03/14/2013 | WO2013006034A3 A diagnostic kit for the detection of early acute leptospirosis |
| 03/14/2013 | WO2013005952A3 System for treating sewerage overflow using apparatus for automatically measuring water quality and dissolved air floatation |
| 03/14/2013 | WO2013005951A3 System for treating sewerage overflow using surfactant micro bubble floatation apparatus for automatically measuring water quality |
| 03/14/2013 | WO2013003624A3 The capture, purification and release of biological substance using a surface coating |
| 03/14/2013 | WO2013001364A3 Extracting mined ore, minerals or other materials using sensor-based sorting |
| 03/14/2013 | WO2013001293A3 Diagnostic method for downs syndrome |
| 03/14/2013 | WO2012177732A3 Measurement of formation porosity using a single gamma ray detector |
| 03/14/2013 | WO2012177640A3 Modulation of tissue transglutaminase activation in disease |
| 03/14/2013 | WO2012177472A3 Online monitoring of contaminants in crude and heavy fuels, and refinery applications thereof |
| 03/14/2013 | WO2012175676A3 Molecules specifically binding pancreatic beta cells biomarkers |